Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 24, Pages 4902-4905
Publisher
American Society of Hematology
Online
2013-05-02
DOI
10.1182/blood-2013-02-486209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
- (2012) A. Agathangelidis et al. BLOOD
- Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling
- (2012) J. A. Burger et al. BLOOD
- Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
- (2012) Davide Rossi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular pathogenesis of chronic lymphocytic leukemia
- (2012) Gianluca Gaidano et al. JOURNAL OF CLINICAL INVESTIGATION
- Cellular origin and pathophysiology of chronic lymphocytic leukemia
- (2012) Marc Seifert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- NOTCH1 mutations in CLL associated with trisomy 12
- (2011) V. Balatti et al. BLOOD
- Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
- (2011) D. Rossi et al. BLOOD
- NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL
- (2011) I. Del Giudice et al. HAEMATOLOGICA
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin
- (2010) C. C. Chu et al. BLOOD
- High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
- (2010) M. Marincevic et al. HAEMATOLOGICA
- The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL
- (2009) F. Forconi et al. BLOOD
- Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins
- (2008) A. Athanasiadou et al. HAEMATOLOGICA
- Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia
- (2008) Bradley T. Messmer et al. LEUKEMIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started